aTYR PHARMA INC Shares Outstanding (Cover Page)
aTYR PHARMA INC (ATYR) had Shares Outstanding (Cover Page) of 98.09 million shares as of 2026-07-31, per its 10-Q filed 2026-08-07.
Financial Statements › Notes › Cover Page
dei:EntityCommonStockSharesOutstanding · last filed 2026-08-07
- 2026-07-31: Entity Common Stock, Shares Outstanding 98.09M shares.
- 2026-05-11: Entity Common Stock, Shares Outstanding 98.05M shares.
- 2026-03-02: Entity Common Stock, Shares Outstanding 98.05M shares.
- 2025-10-31: Entity Common Stock, Shares Outstanding 97.99M shares.
| Period end | Entity Common Stock, Shares Outstanding |
|---|---|
| 2026-07-31 | 98.09M shares 10-Q · filed 2026-08-07 |
| 2026-05-11 | 98.05M shares 10-Q · filed 2026-05-15 |
| 2026-03-02 | 98.05M shares 10-K · filed 2026-03-05 |
| 2025-10-31 | 97.99M shares 10-Q · filed 2025-11-06 |
| 2025-08-01 | 97.99M shares 10-Q · filed 2025-08-07 |
| 2025-05-02 | 89.00M shares 10-Q · filed 2025-05-07 |
| 2025-03-07 | 88.86M shares 10-K · filed 2025-03-13 |
| 2024-11-05 | 83.94M shares 10-Q · filed 2024-11-07 |
| 2024-08-09 | 75.80M shares 10-Q · filed 2024-08-13 |
| 2024-04-30 | 69.01M shares 10-Q · filed 2024-05-02 |
| 2024-03-08 | 67.75M shares 10-K · filed 2024-03-14 |
| 2023-11-03 | 58.56M shares 10-Q · filed 2023-11-09 |
| 2023-08-04 | 57.05M shares 10-Q · filed 2023-08-09 |
| 2023-05-05 | 54.29M shares 10-Q · filed 2023-05-09 |
| 2023-03-10 | 53.16M shares 10-K · filed 2023-03-14 |
| 2022-11-08 | 29.01M shares 10-Q · filed 2022-11-14 |
| 2022-08-12 | 28.63M shares 10-Q · filed 2022-08-15 |
| 2022-05-04 | 28.06M shares 10-Q · filed 2022-05-10 |
| 2022-03-10 | 27.80M shares 10-K · filed 2022-03-15 |
| 2021-11-09 | 27.79M shares 10-Q · filed 2021-11-12 |
| 2021-08-09 | 16.92M shares 10-Q · filed 2021-08-11 |
| 2021-05-07 | 16.06M shares 10-Q · filed 2021-05-14 |
| 2021-03-19 | 16.01M shares 10-K · filed 2021-03-24 |
| 2020-11-06 | 10.12M shares 10-Q · filed 2020-11-13 |
| 2020-08-07 | 9.54M shares 10-Q · filed 2020-08-13 |
| 2020-05-08 | 9.35M shares 10-Q · filed 2020-05-12 |
| 2020-03-19 | 9.35M shares 10-K · filed 2020-03-26 |
| 2019-11-08 | 3.89M shares 10-Q · filed 2019-11-14 |
| 2019-08-07 | 3.89M shares 10-Q · filed 2019-08-14 |
| 2019-05-10 | 45.74M shares 10-Q · filed 2019-05-14 |
| 2019-03-15 | 34.77M shares 10-K · filed 2019-03-26 |
| 2018-11-08 | 30.02M shares 10-Q · filed 2018-11-14 |
| 2018-08-07 | 29.86M shares 10-Q · filed 2018-08-14 |
| 2018-05-07 | 29.83M shares 10-Q · filed 2018-05-15 |
| 2018-03-15 | 29.80M shares 10-K · filed 2018-03-20 |
| 2017-11-07 | 29.76M shares 10-Q · filed 2017-11-14 |
| 2017-08-04 | 23.84M shares 10-Q · filed 2017-08-14 |
| 2017-05-10 | 23.81M shares 10-Q · filed 2017-05-11 |
| 2017-03-08 | 23.75M shares 10-K · filed 2017-03-16 |
| 2016-11-07 | 23.72M shares 10-Q · filed 2016-11-14 |
| 2016-08-05 | 23.72M shares 10-Q · filed 2016-08-10 |
| 2016-05-06 | 23.69M shares 10-Q · filed 2016-05-11 |
| 2016-03-24 | 23.68M shares 10-K · filed 2016-03-30 |
| 2015-11-06 | 23.65M shares 10-Q · filed 2015-11-10 |
| 2015-08-07 | 23.64M shares 10-Q · filed 2015-08-12 |
| 2015-06-10 | 23.63M shares 10-Q · filed 2015-06-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Quince Therapeutics, Inc. (QNCX) | United States | $0.031B | |
| CEL SCI CORP (CVM) | United States | $0.030B | -0.81 |
| Scilex Holding Co (SCLX) | United States | $0.042B | -0.14 |
| Metagenomi Therapeutics, Inc. (MGX) | United States | $0.044B | -0.48 |
| Estrella Immunopharma, Inc. (ESLA) | United States | $0.020B | |
| LeonaBio, Inc. (LONA) | United States | $0.047B | -0.61 |
| Jasper Therapeutics, Inc. (JSPR) | United States | $0.020B | -0.37 |
| Instil Bio, Inc. (TIL) | United States | $0.048B | -1.73 |
| Tevogen Inc. (TVGN) | United States | $0.049B | |
| BioCardia, Inc. (BCDA) | United States | $0.016B |